Filing Details
- Accession Number:
- 0001062993-19-002531
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-06 16:45:06
- Reporting Period:
- 2019-06-04
- Accepted Time:
- 2019-06-06 16:45:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875622 | Biospecifics Technologies Corp | BSTC | Pharmaceutical Preparations (2834) | 113054851 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1639625 | M Jennifer Chao | C/O Biospecifics Technologies Corp. 35 Wilbur Street Lynbrook NY 11563 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value | Disposition | 2019-06-04 | 2,600 | $56.56 | 3,400 | No | 4 | S | Direct | |
| Common Stock, $0.001 Par Value | Disposition | 2019-06-05 | 2,411 | $58.01 | 989 | No | 4 | S | Direct | |
| Common Stock, $0.001 Par Value | Disposition | 2019-06-05 | 500 | $57.25 | 489 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The selling price of $56.56 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $56.50 to $56.60. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The selling price of $58.01 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $57.80 to $58.60. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
